GENUS PHARMACEUTICALS LIMITED

Active Huddersfield

Manufacture of pharmaceutical preparations

2 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparationsWholesale of pharmaceutical goods
G

GENUS PHARMACEUTICALS LIMITED

Manufacture of pharmaceutical preparations

Founded 6 Feb 1986 Active Huddersfield, England 2 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparationsWholesale of pharmaceutical goods

Previous Company Names

SCHEIN PHARMACEUTICAL UK LIMITED 10 Sept 1999 — 30 Jun 2004
ETHICAL GENERICS LIMITED 26 Jun 1987 — 10 Sept 1999
ETHICAL PHARMACEUTICALS LIMITED 6 Feb 1986 — 26 Jun 1987
Accounts Submitted 4 Jun 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 10 Nov 2025 Next due 23 Nov 2026 6 months remaining
Net assets £87M £3M 2024 year on year
Total assets £99M £3M 2024 year on year
Total Liabilities £12M £89K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Linthwaite Labs Manchester Road Linthwaite Huddersfield HD7 5QH England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for GENUS PHARMACEUTICALS LIMITED (01986459), an active life sciences and medical technology company based in Huddersfield, England. Incorporated 6 Feb 1986. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£87.03M

Increased by £2.79M (+3%)

Total Liabilities

£12.29M

Decreased by £89.00k (-1%)

Turnover

£14.42M

Decreased by £8.70M (-38%)

Employees

2

Debt Ratio

12%

Decreased by 1 (-8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Genus Pharmaceuticals Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 1 Jul 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GENUS PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Nov 2025Confirmation StatementConfirmation statement made on 9 Nov 2025 with no updates
5 Nov 2025OfficersAppointment of Mr Craig Richard Shaw as director on 3 Nov 2025
4 Nov 2025OfficersTermination of Volker Sydow as director on 3 Nov 2025
6 Aug 2025OfficersTermination of Nigel David Stephenson as director on 31 Jul 2025
20 Jun 2025OfficersAppointment of Mr Volker Sydow as director on 17 Jun 2025
10 Nov 2025 Confirmation Statement

Confirmation statement made on 9 Nov 2025 with no updates

5 Nov 2025 Officers

Appointment of Mr Craig Richard Shaw as director on 3 Nov 2025

4 Nov 2025 Officers

Termination of Volker Sydow as director on 3 Nov 2025

6 Aug 2025 Officers

Termination of Nigel David Stephenson as director on 31 Jul 2025

20 Jun 2025 Officers

Appointment of Mr Volker Sydow as director on 17 Jun 2025

Recent Activity

Latest Activity

Confirmation statement made on 9 Nov 2025 with no updates

6 months ago on 10 Nov 2025

Appointment of Mr Craig Richard Shaw as director on 3 Nov 2025

6 months ago on 5 Nov 2025

Termination of Volker Sydow as director on 3 Nov 2025

6 months ago on 4 Nov 2025

Termination of Nigel David Stephenson as director on 31 Jul 2025

9 months ago on 6 Aug 2025

Appointment of Mr Volker Sydow as director on 17 Jun 2025

10 months ago on 20 Jun 2025